Results 91 to 100 of about 114,570 (194)

Feasibility and outcomes of kidney transplantation in patients with end‐stage kidney disease after haemopoietic stem cell transplantation

open access: yesInternal Medicine Journal, Volume 56, Issue 7, Page 1174-1181, July 2026.
Abstract Background Advances in haemopoietic stem cell transplantation (HSCT) have improved long‐term survival, but they have also led to late complications, such as nephropathy. However, the safety and feasibility of kidney transplantation (KT) in patients with HSCT‐related end‐stage kidney disease (ESKD) remain unclear.
Bioh Kim   +6 more
wiley   +1 more source

Management of Severe Autoimmune Hemolytic Anemia: Incompatible Blood Transfusion as A Life-Saving Strategy

open access: yesNational Journal of Medical Research
Background: Autoimmune hemolytic anemia (AIHA) presents with severe anemia requiring urgent transfusion, but serological incompatibility poses challenges.
Digeet Davad   +3 more
doaj   +1 more source

Safety and efficacy of least incompatible red cell units in autoimmune hemolytic anemia: A prospective analysis of hemoglobin increment and hemolysis after transfusion

open access: yesAsian Journal of Transfusion Science
BACKGROUND: Red blood cell (RBC) transfusion is a challenge in autoimmune hemolytic anemia (AIHA) patients due to pan reactivity and crossmatch incompatibility.
Harsha Michael   +3 more
doaj   +1 more source

Evaluation of a two-sample process for prevention of ABO mistransfusions in a high volume academic hospital

open access: yesBMJ Open Quality, 2018
Background Acute haemolytic transfusion reactions due to ABO incompatible blood transfusion remain a leading cause of transfusion-associated morbidity and mortality in the USA.
Chad Glisch   +6 more
doaj   +1 more source

EVALUATION OF INCOMPATIBLE CROSSMATCHES AT A TERTIARY CARE HOSPITAL IN CHENNAI – A PROSPECTIVE STUDY

open access: yesAsian Journal of Pharmaceutical and Clinical Research
Objectives: The primary goal in blood transfusion is that the transfused blood unit be compatible with the patient during crossmatching. This compatibility testing is performed before every administration of blood component. This cross-matching test helps to detect the presence of antibodies in the recipient against antigens over red blood cells of ...
ShoganRaj S   +3 more
openaire   +1 more source

Assessing risk in liver transplantation: Special reference to the significance of a positive cytotoxic crossmatch [PDF]

open access: yes, 1996
Objective: The authors determined the impact of a positive cytotoxic crossmatch on the outcome of liver transplantation. Summary Background Data: Liver allografts rarely undergo hyperacute rejection, but transplants performed across a positive cytotoxic ...
Doria, C   +27 more
core   +1 more source

Evaluation of Incompatible Crossmatch at a Tertiary Care Blood Center

open access: yesInternational Journal of Science and Research (IJSR), 2021
Tejal Ahuja   +5 more
openaire   +1 more source

The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors [PDF]

open access: yes, 1992
Because of the liver graft's ability to resist cytotoxic antibody-mediated rejection, it has become dogma that the conventional transplant crossmatch used to avoid hyperacute rejection of other organs is irrelevant to the liver.
Todo, S   +11 more
core   +1 more source

Is routine preoperative crossmatch appropriate for elective laparoscopic cholecystectomy? [PDF]

open access: yes, 2017
Background : Inappropriate cross-matching results in a costly waste of resources. A 12-monthreport from our blood bank demonstrated an inappropriate use of preoperative blood order with the crossmatch to transfusion (C/T) ratio of 2.08.Objective : The ...
Wongswadiwat, Malinee   +5 more
core  

Outcomes of Kidney Transplantation in Highly HLA-Sensitized Patients Treated with Intravenous Immuno-Globulin, Plasmapheresis and Rituximab: A Meta-Analysis

open access: yesLife
(1) Background: We aimed to investigate the outcomes of human leukocyte antigen (HLA)-incompatible transplantation for patients who received desensitization with intravenous immunoglobulins (IVIg), plasmapheresis, and rituximab.
Deepak Chandramohan   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy